These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 30985413)
21. Detection of Bone Metastases by Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752 [TBL] [Abstract][Full Text] [Related]
22. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
23. Al Diao W; Ye Z; Kou Y; Cheng Z Hell J Nucl Med; 2024; 27(1):68-70. PubMed ID: 38629821 [TBL] [Abstract][Full Text] [Related]
24. A comparison of [ Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909 [TBL] [Abstract][Full Text] [Related]
25. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518 [TBL] [Abstract][Full Text] [Related]
26. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of Zhu W; Cheng Y; Jia R; Zhao H; Bai C; Xu J; Yao S; Huo L J Nucl Med; 2021 Oct; 62(10):1398-1405. PubMed ID: 33579804 [No Abstract] [Full Text] [Related]
27. Li J Front Endocrinol (Lausanne); 2024; 15():1400751. PubMed ID: 38887276 [TBL] [Abstract][Full Text] [Related]
29. Functional imaging in neuroendocrine tumors: assessment of molecular heterogeneity using [ Nogareda Seoane Z; Mallón Araújo MC; Calatayud Cubes A; Barberán Corral C; Domínguez Novoa Y; Cousillas Castiñeira A; Martínez Lago N; de Matías Leralta JM; Pubul Nuñez V Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500011. PubMed ID: 38643835 [TBL] [Abstract][Full Text] [Related]
30. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872 [TBL] [Abstract][Full Text] [Related]
31. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia. Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458 [TBL] [Abstract][Full Text] [Related]
32. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651 [No Abstract] [Full Text] [Related]
33. Clinical Usefulness of Rinzivillo M; Partelli S; Prosperi D; Capurso G; Pizzichini P; Iannicelli E; Merola E; Muffatti F; Scopinaro F; Schillaci O; Salgarello M; Falconi M; Delle Fave G; Panzuto F Oncologist; 2018 Feb; 23(2):186-192. PubMed ID: 29118267 [TBL] [Abstract][Full Text] [Related]
34. PET imaging of CXCR4 expression using [ Cheng K; Wang S; Liu T; Pei J; Wang S; Liu J; Zhao K; Luo Y; Xu S; Yu J; Liu J Theranostics; 2024; 14(16):6337-6349. PubMed ID: 39431004 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Hou J; Long T; He Z; Zhou M; Yang N; Chen D; Zeng S; Hu S EJNMMI Res; 2021 Jun; 11(1):55. PubMed ID: 34106351 [TBL] [Abstract][Full Text] [Related]
36. Safety, Biodistribution, and Radiation Dosimetry of Nicolas GP; Beykan S; Bouterfa H; Kaufmann J; Bauman A; Lassmann M; Reubi JC; Rivier JEF; Maecke HR; Fani M; Wild D J Nucl Med; 2018 Jun; 59(6):909-914. PubMed ID: 29025985 [TBL] [Abstract][Full Text] [Related]
37. High in-vivo stability in preclinical and first-in-human experiments with [ Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493 [TBL] [Abstract][Full Text] [Related]
38. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors. Abdulrezzak U; Kurt YK; Kula M; Tutus A Nucl Med Commun; 2016 Aug; 37(8):874-81. PubMed ID: 27096719 [TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients. Johnbeck CB; Knigge U; Langer SW; Loft A; Berthelsen AK; Federspiel B; Binderup T; Kjaer A J Nucl Med; 2016 Dec; 57(12):1851-1857. PubMed ID: 27469355 [TBL] [Abstract][Full Text] [Related]
40. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]